Panel Member
(Spouse/Domestic Partner/Dependent) |
Clinical Research Support/Data Safety Monitoring Board | Scientific Advisory Boards, Consultant, or Expert Witness | Promotional Advisory Boards, Consultant, or Speakers Bureau | Employment/ Governing Board, Patent, Equity, or Royalty | Date Completed |
---|---|---|---|---|---|
Zahraa AlHilli MD | None | None | None | None | 01/03/2024 |
Banu Arun MD | AstraZeneca Pharmaceuticals LP | None | None | None | 01/29/2024 |
Marian Birkeland PhD | None | None | None | None | 04/02/2024 |
Nicole Blankenhorn | None | None | None | None | 03/04/2024 |
Saundra Buys MD | None | None | None | None | 02/05/2024 |
Heather Cheng PhD,MD | Clovis Oncology Color Health, Inc Janssen Pharmaceutica Products, LP Promontory Therapeutics (formerly Phosplatin) |
None | None | UpToDate | 12/22/2023 |
Jane Churpek MS,MD | Department of Defense NIH |
MDS Foundation RUNX1 Research Program |
None | MDS Foundation|RUNX1 Research Program | 04/24/2024 |
Mary Daly PhD,MD,FACP | None | None | None | None | 01/25/2024 |
Susan Darlow PhD | None | None | None | None | 04/17/2024 |
Zeenat Diwan PhD,MS | None | None | None | None | 12/11/2023 |
Susan Domchek MD | Glade Therapuetics | None | None | None | 03/18/2024 |
Mary Dwyer MS | None | None | None | None | 02/12/2024 |
Susan Friedman DVM | None | None | None | None | 02/05/2024 |
Veda Giri MD | None | None | None | None | 03/25/2024 |
Michael Goggins MD | None | None | None | None | 12/27/2023 |
Kristina Gregory MSN,RN | None | None | None | None | 01/10/2024 |
Andrea Hagemann MD,MSCI | None | None | None | None | 11/27/2023 |
Ashley Hendrix MD,MBA | None | None | None | None | 04/02/2024 |
Erin Hesler | None | None | None | None | 12/22/2023 |
Dezheng Huo PhD | None | None | None | None | 04/24/2024 |
Mollie Hutton MS,CGC | None | None | None | None | 01/03/2024 |
Beth Karlan MD | GRAIL | ACS BrightEdge ClearNote Foundation Medicine Global Coalition for Adaptive Research Invitae Mercy BioAnalytics Ovarian Cancer Research Alliance |
None | None | 04/23/2024 |
Nawal Kassem MS,MD | None | None | None | None | 03/18/2024 |
Seema Khan MD | None | Besins Healthcare Ireland Ltd. | None | None | 12/22/2023 |
Katia Khoury MD | None | None | None | None | 02/11/2024 |
Allison Kurian MSc,MD | Ambry Genetics Color Health GeneDx Gilead Sciences, Inc. GRAIL Invitae Merck & Co., Inc. Myriad Genetic Laboratories, Inc. |
None | None | None | 04/11/2024 |
Christine Laronga MD,FACS | None | None | None | Royalties for editorial work | 01/28/2024 |
Julie Mak MSc,MS,CGC | None | None | None | VSee | 11/28/2023 |
John Mansour MD | None | None | None | None | 02/05/2024 |
Kara Maxwell PhD,MD | None | None | None | None | 03/19/2024 |
Kevin McDonnell PhD,MD | None | None | None | None | 02/03/2024 |
Carolyn Menendez MD | None | None | None | None | 04/16/2024 |
Sofia Merajver PhD,MD | Inheret, LLC National Institutes of Health |
Inheret, LLC | None | Founder and equity interest in InheRET, Inc. I do not believe that any change in the guidelines would benefit or harm the commercial potential of InheRET, Inc. | 02/05/2024 |
Barbara Norquist MD | None | None | None | None | 03/18/2024 |
Kenneth Offit MD,MPH | None | None | None | None | 04/04/2024 |
Tuya Pal MD | None | None | None | None | 02/27/2024 |
Donna Powell CMD,DHSc,RT(T) | None | None | None | None | 03/13/2024 |
Dominique Rash MD | None | None | None | None | 02/06/2024 |
Gwen Reiser MS,CGC | None | None | None | None | 03/18/2024 |
Leigha Senter-Jamieson MS,CGC | None | AstraZeneca Pharmaceuticals LP | AstraZeneca Pharmaceuticals LP | None | 01/03/2024 |
Kristen Shannon MS,CGC | None | None | None | None | 04/07/2024 |
Kala Visvanathan MHS,MD | Cepheid Optra Health |
Evolveimmune Therapeutics Vera Medical Institute |
None | None | 03/18/2024 |
Jeanna Welborn MD | None | None | None | None | 02/20/2024 |
Myra Wick MD,PhD | Natera | American board of Medical Genetics and Genomics (ABMGG) | None | None | 03/05/2024 |
Marie Wood MD | None | None | None | None | 03/18/2024 |
Matthew Yurgelun MD | Janssen Pharmaceutica Products, LP | Nouscom UpToDate |
None | Facing Our Risk of Cancer Empowered (FORCE) advocacy group | 03/16/2024 |